Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, et al. (2000) A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 95: 17–31.
[2]
Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. (2007) NCBI GEO: Mining tens of millions of expression profiles—Database and tools update. Nucleic Acids Res 35: D760–D765.
[3]
Parkinson H, Kapushesky M, Shojatalab M, Abeygunawardena N, Coulson R, et al. (2007) ArrayExpress—A public database of microarray experiments and gene expression profiles. Nucleic Acids Res 35: D747–D750.
[4]
Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6: 1–6.
[5]
Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, et al. (2008) Human Proteinpedia enables sharing of human protein data. Nat Biotechnol 26: 164–167.
[6]
Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, et al. (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28: 977–987.
[7]
Buchholz M, Braun M, Heidenblut A, Kestler HA, Kloppel G, et al. (2005) Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24: 6626–6636.
[8]
Ekbom A, McLaughlin JK, Karlsson BM, Nyren O, Gridley G, et al. (1994) Pancreatitis and pancreatic cancer: A population-based study. J Natl Cancer Inst 86: 625–627.
[9]
Chen R, Pan S, Cooke K, Moyes KW, Bronner MP, et al. (2007) Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas 34: 70–79.
[10]
Zeh HJ, Winikoff S, Landsittel DP, Gorelik E, Marrangoni AM, et al. (2005) Multianalyte profiling of serum cytokines for detection of pancreatic cancer. Cancer Biomark 1: 259–269.
[11]
Chen R, Brentnall TA, Pan S, Cooke K, Moyes KW, et al. (2007) Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics 6: 1331–1342.
[12]
Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, et al. (2007) CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 34: 436–443.
[13]
Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, et al. (2006) New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol 24: 252–258.
[14]
Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918–926.
[15]
Infante JR, Matsubayashi H, Sato N, Tonascia J, Klein AP, et al. (2007) Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J Clin Oncol 25: 319–325.
[16]
Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, et al. (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64: 2634–2638.
[17]
Maitra A, Ashfaq R, Gunn CR, Rahman A, Yeo CJ, et al. (2002) Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: An immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol 118: 194–201.
[18]
Karanjawala ZE, Illei PB, Ashfaq R, Infante JR, Murphy K, et al. (2008) New markers of pancreatic cancer identified through differential gene expression analyses: Claudin 18 and annexin A8. Am J Surg Pathol 32: 188–196.
[19]
Foss CA, Fox JJ, Feldmann G, Maitra A, Iacobuzio-Donohue C, et al. (2007) Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: Initial imaging in experimental models of pancreatic cancer. Mol Imaging 6: 131–139.
[20]
Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, et al. (2001) Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 61: 4320–4324.
